Research Site

Altındağ-Ankara 06230

1 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, Asthma, Dermatomyositis

Studies at this site

• Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer — Recruiting now
• A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations — Completed
• Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis — Stopped early